Cytosorbents Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-14.0M | $-17.6M | $3.6M | $4.0M |
| FY2022 | $-28.2M | $-34.3M | $6.1M | $3.4M |
| FY2023 | $-21.7M | $-22.2M | $538.1K | $4.2M |
| FY2024 | $-14.4M | $-14.7M | $284.0K | $3.8M |
| FY2025 | $-12.4M | $-12.5M | $164.0K | $2.8M |